Prevention of Arrhythmia Device Infection Trial (PADIT)

NCT01613092 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

241

Enrollment

OTHER

Sponsor class

Conditions

Arrhythmia

Interventions

DRUG: Incremental
DRUG: Cefazolin

Sponsor

Population Health Research Institute